US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist

1.2800
+0.0200+1.59%

Close Nov 21 16:00 ET

1.2501
-0.0299-2.34%

Post 20:01 ET

3.56MMarket Cap-39P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.51%-3.91M

11.31%-3.45M

12.99%-4.88M

0.45%-19M

-21.85%-6.54M

33.73%-2.95M

10.65%-3.89M

-14.44%-5.61M

-48.04%-19.08M

-11.60%-5.37M

Net income from continuing operations

-134.02%-7.73M

-63.54%-8.32M

-15.34%-5.17M

6.79%-18.35M

14.90%-5.49M

26.48%-3.3M

-13.58%-5.09M

-4.80%-4.48M

-37.97%-19.69M

-22.46%-6.45M

Depreciation and amortization

3.13%33K

18.75%38K

21.88%39K

58.82%135K

56.00%39K

33.33%32K

77.78%32K

-2.30%85K

92.31%25K

Deferred tax

57.31%-225K

38.44%-221K

32.42%-223K

-15.09%-1.64M

24.01%-424K

-57.31%-527K

32.52%-359K

---330K

---1.43M

---558K

Other non cash items

149.35%723K

-134.59%-184K

42.86%310K

-188.08%-2M

-154.05%-1.29M

-697.96%-1.47M

234.01%532K

382.22%217K

1,269.88%2.27M

--2.38M

Change In working capital

-88.36%253K

17.70%991K

99.83%-2K

386.48%2.31M

152.33%471K

10,447.62%2.17M

-8.38%842K

-46.39%-1.18M

-213.68%-806K

-652.15%-900K

-Change in prepaid assets

-92.45%107K

-49.60%252K

271.36%766K

461.98%1.31M

86.35%-156K

440.84%1.42M

290.63%500K

-214.62%-447K

-308.62%-363K

-929.73%-1.14M

-Change in payables and accrued expense

-68.83%269K

91.95%858K

-3.65%-653K

544.20%1.42M

207.08%737K

435.80%863K

-46.98%447K

44.98%-630K

-142.48%-319K

-46.07%240K

-Change in other current liabilities

-14.95%-123K

-13.33%-119K

-15.00%-115K

-240.32%-422K

-3,766.67%-110K

-311.54%-107K

-101.92%-105K

-104.08%-100K

42.59%-124K

106.25%3K

Cash from discontinued investing activities

Operating cash flow

-32.51%-3.91M

11.31%-3.45M

12.99%-4.88M

0.45%-19M

-21.85%-6.54M

33.73%-2.95M

10.65%-3.89M

-14.44%-5.61M

-48.04%-19.08M

-11.60%-5.37M

Investing cash flow

Cash flow from continuing investing activities

88.89%-1K

95.40%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

99.81%-8K

-31,300.00%-4.4M

-91K

Net PPE purchase and sale

--0

88.89%-1K

--0

-74.14%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

---8K

-728.57%-116K

---91K

Net business purchase and sale

----

--0

----

---4.28M

--0

Cash from discontinued investing activities

Investing cash flow

--0

88.89%-1K

--0

95.40%-202K

38.46%-56K

-1,072.73%-129K

35.71%-9K

99.81%-8K

-31,300.00%-4.4M

---91K

Financing cash flow

Cash flow from continuing financing activities

371,500.00%3.72M

-16.99%1.77M

132.38%625K

55.69%-1.46M

-99.96%1K

2.14M

96.00%-55K

-102.61%-1.93M

-3.29M

Net issuance payments of debt

--0

-235.00%-67K

--0

94.55%-75K

--0

---20K

96.00%-55K

---1.38M

--0

Net common stock issuance

371,500.00%3.72M

----

870.49%2.22M

121.53%62K

--1K

----

-100.44%-288K

---288K

Net preferred stock issuance

----

--0

----

--2.73M

--0

Net other financing activities

----

49.37%-1.52M

----

---3M

----

Cash from discontinued financing activities

Financing cash flow

371,500.00%3.72M

-16.99%1.77M

--0

132.38%625K

55.69%-1.46M

-99.96%1K

--2.14M

96.00%-55K

-102.61%-1.93M

---3.29M

Net cash flow

Beginning cash position

-51.40%16.69M

-49.25%18.36M

-44.42%23.28M

-37.79%41.89M

-38.20%31.26M

-34.40%34.35M

-36.30%36.18M

-37.79%41.88M

981.18%67.33M

-29.88%50.58M

Current changes in cash

93.61%-197K

4.82%-1.68M

13.96%-4.88M

26.90%-18.57M

7.92%-8.05M

-77.78%-3.08M

59.61%-1.77M

46.27%-5.67M

-141.59%-25.41M

-81.85%-8.75M

Effect of exchange rate changes

254.55%17K

119.05%12K

-8.57%-38K

-3.13%-33K

46.15%76K

77.55%-11K

0.00%-63K

-225.00%-35K

---32K

--52K

End cash Position

-47.17%16.51M

-51.40%16.69M

-49.25%18.36M

-44.42%23.28M

-38.20%31.26M

-34.40%34.35M

-36.30%36.18M

-37.79%41.89M

Free cash flow

-26.96%-3.91M

11.48%-3.45M

13.12%-4.88M

0.00%-19.2M

-20.85%-6.6M

31.01%-3.08M

10.73%-3.9M

-14.61%-5.62M

-48.78%-19.2M

-13.49%-5.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.51%-3.91M	11.31%-3.45M	12.99%-4.88M	0.45%-19M	-21.85%-6.54M	33.73%-2.95M	10.65%-3.89M	-14.44%-5.61M	-48.04%-19.08M	-11.60%-5.37M
Net income from continuing operations	-134.02%-7.73M	-63.54%-8.32M	-15.34%-5.17M	6.79%-18.35M	14.90%-5.49M	26.48%-3.3M	-13.58%-5.09M	-4.80%-4.48M	-37.97%-19.69M	-22.46%-6.45M
Depreciation and amortization	3.13%33K	18.75%38K	21.88%39K	58.82%135K	56.00%39K	33.33%32K	77.78%32K	77.78%32K	-2.30%85K	92.31%25K
Deferred tax	57.31%-225K	38.44%-221K	32.42%-223K	-15.09%-1.64M	24.01%-424K	-57.31%-527K	32.52%-359K	---330K	---1.43M	---558K
Other non cash items	149.35%723K	-134.59%-184K	42.86%310K	-188.08%-2M	-154.05%-1.29M	-697.96%-1.47M	234.01%532K	382.22%217K	1,269.88%2.27M	--2.38M
Change In working capital	-88.36%253K	17.70%991K	99.83%-2K	386.48%2.31M	152.33%471K	10,447.62%2.17M	-8.38%842K	-46.39%-1.18M	-213.68%-806K	-652.15%-900K
-Change in prepaid assets	-92.45%107K	-49.60%252K	271.36%766K	461.98%1.31M	86.35%-156K	440.84%1.42M	290.63%500K	-214.62%-447K	-308.62%-363K	-929.73%-1.14M
-Change in payables and accrued expense	-68.83%269K	91.95%858K	-3.65%-653K	544.20%1.42M	207.08%737K	435.80%863K	-46.98%447K	44.98%-630K	-142.48%-319K	-46.07%240K
-Change in other current liabilities	-14.95%-123K	-13.33%-119K	-15.00%-115K	-240.32%-422K	-3,766.67%-110K	-311.54%-107K	-101.92%-105K	-104.08%-100K	42.59%-124K	106.25%3K
Cash from discontinued investing activities
Operating cash flow	-32.51%-3.91M	11.31%-3.45M	12.99%-4.88M	0.45%-19M	-21.85%-6.54M	33.73%-2.95M	10.65%-3.89M	-14.44%-5.61M	-48.04%-19.08M	-11.60%-5.37M
Investing cash flow
Cash flow from continuing investing activities	0	88.89%-1K	0	95.40%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	99.81%-8K	-31,300.00%-4.4M	-91K
Net PPE purchase and sale	--0	88.89%-1K	--0	-74.14%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	---8K	-728.57%-116K	---91K
Net business purchase and sale	----	----	----	--0	----	----	----	----	---4.28M	--0
Cash from discontinued investing activities
Investing cash flow	--0	88.89%-1K	--0	95.40%-202K	38.46%-56K	-1,072.73%-129K	35.71%-9K	99.81%-8K	-31,300.00%-4.4M	---91K
Financing cash flow
Cash flow from continuing financing activities	371,500.00%3.72M	-16.99%1.77M	0	132.38%625K	55.69%-1.46M	-99.96%1K	2.14M	96.00%-55K	-102.61%-1.93M	-3.29M
Net issuance payments of debt	--0	-235.00%-67K	--0	94.55%-75K	--0	--0	---20K	96.00%-55K	---1.38M	--0
Net common stock issuance	371,500.00%3.72M	----	----	870.49%2.22M	121.53%62K	--1K	----	----	-100.44%-288K	---288K
Net preferred stock issuance	----	----	----	--0	----	----	----	----	--2.73M	--0
Net other financing activities	----	----	----	49.37%-1.52M	----	----	----	----	---3M	----
Cash from discontinued financing activities
Financing cash flow	371,500.00%3.72M	-16.99%1.77M	--0	132.38%625K	55.69%-1.46M	-99.96%1K	--2.14M	96.00%-55K	-102.61%-1.93M	---3.29M
Net cash flow
Beginning cash position	-51.40%16.69M	-49.25%18.36M	-44.42%23.28M	-37.79%41.89M	-38.20%31.26M	-34.40%34.35M	-36.30%36.18M	-37.79%41.88M	981.18%67.33M	-29.88%50.58M
Current changes in cash	93.61%-197K	4.82%-1.68M	13.96%-4.88M	26.90%-18.57M	7.92%-8.05M	-77.78%-3.08M	59.61%-1.77M	46.27%-5.67M	-141.59%-25.41M	-81.85%-8.75M
Effect of exchange rate changes	254.55%17K	119.05%12K	-8.57%-38K	-3.13%-33K	46.15%76K	77.55%-11K	0.00%-63K	-225.00%-35K	---32K	--52K
End cash Position	-47.17%16.51M	-51.40%16.69M	-49.25%18.36M	-44.42%23.28M	-44.42%23.28M	-38.20%31.26M	-34.40%34.35M	-36.30%36.18M	-37.79%41.89M	-37.79%41.89M
Free cash flow	-26.96%-3.91M	11.48%-3.45M	13.12%-4.88M	0.00%-19.2M	-20.85%-6.6M	31.01%-3.08M	10.73%-3.9M	-14.61%-5.62M	-48.78%-19.2M	-13.49%-5.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data